TY - JOUR
T1 - Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders
AU - Hagihara, Hideo
AU - Catts, Vibeke S.
AU - Katayama, Yuta
AU - Shoji, Hirotaka
AU - Takagi, Tsuyoshi
AU - Huang, Freesia L.
AU - Nakao, Akito
AU - Mori, Yasuo
AU - Huang, Kuo Ping
AU - Ishii, Shunsuke
AU - Graef, Isabella A.
AU - Nakayama, Keiichi I.
AU - Shannon Weickert, Cynthia
AU - Miyakawa, Tsuyoshi
N1 - Funding Information:
TM received research grants from Astellas Pharma Inc. CSW is on an advisory board for Lundbeck, Australia Pty Ltd and in collaboration with Astellas Pharma Inc. CSW is funded by the NSW Ministry of Health, Office of Health and Medical Research. CSW is a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF) (#1117079). CSW and VSC received tissues from the New South Wales Brain Tissue Resource Centre at the University of Sydney which is supported by the University of Sydney and The Schizophrenia Research Institute (Fillman et al, 2013). Research reported in this publication was supported by the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number R28AA012725. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
Funding Information:
We thank Gerald R Crabtree of Stanford University for providing Cn mutant mice, Wakako Hasegawa, Yumiko Mobayashi, Misako Murai, Tamaki Murakami, Miwa Takeuchi, Aki Miyakawa, Chikako Ozeki, Yuya Ouchi, Satoko Hattori, Toshiki Kameyama, Hidehito Inagaki, and Hiroki Kurahashi of Fujita Health University for their technical support in this study, as well as Yuki Sugiura of Keio University for helpful discussion. This work was supported by the Grants-in-Aid for Scientific Research (JP25242078) from Japan Society for the Promotion of Science; the Grant-in-Aid for Scientific Research on Innovative Areas ‘‘Unraveling the microendophenotypes of psychiatric disorders at the molecular, cellular and circuit levels’’ (JP25116526, JP15H01297) and ‘‘Dynamic regulation of brain function by Scrap & Build system’’ (JP16H06462) from the Ministry of Education, Culture, Sports, Science and Technology; and the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Although the brains of patients with schizophrenia and bipolar disorder exhibit decreased brain pH relative to those of healthy controls upon postmortem examination, it remains controversial whether this finding reflects a primary feature of the diseases or is a result of confounding factors such as medication and agonal state. To date, systematic investigation of brain pH has not been undertaken using animal models that can be studied without confounds inherent in human studies. In the present study, we first reevaluated the pH of the postmortem brains of patients with schizophrenia and bipolar disorder by conducting a meta-analysis of existing data sets from 10 studies. We then measured pH, lactate levels, and related metabolite levels in brain homogenates from five neurodevelopmental mouse models of psychiatric disorders, including schizophrenia, bipolar disorder, and autism spectrum disorder. All mice were drug naive with the same agonal state, postmortem interval, and age within each strain. Our meta-analysis revealed that brain pH was significantly lower in patients with schizophrenia and bipolar disorder than in control participants, even when a few potential confounding factors (postmortem interval, age, and history of antipsychotic use) were considered. In animal experiments, we observed significantly lower pH and higher lactate levels in the brains of model mice relative to controls, as well as a significant negative correlation between pH and lactate levels. Our findings suggest that lower pH associated with increased lactate levels is not a mere artifact, but rather implicated in the underlying pathophysiology of schizophrenia and bipolar disorder.
AB - Although the brains of patients with schizophrenia and bipolar disorder exhibit decreased brain pH relative to those of healthy controls upon postmortem examination, it remains controversial whether this finding reflects a primary feature of the diseases or is a result of confounding factors such as medication and agonal state. To date, systematic investigation of brain pH has not been undertaken using animal models that can be studied without confounds inherent in human studies. In the present study, we first reevaluated the pH of the postmortem brains of patients with schizophrenia and bipolar disorder by conducting a meta-analysis of existing data sets from 10 studies. We then measured pH, lactate levels, and related metabolite levels in brain homogenates from five neurodevelopmental mouse models of psychiatric disorders, including schizophrenia, bipolar disorder, and autism spectrum disorder. All mice were drug naive with the same agonal state, postmortem interval, and age within each strain. Our meta-analysis revealed that brain pH was significantly lower in patients with schizophrenia and bipolar disorder than in control participants, even when a few potential confounding factors (postmortem interval, age, and history of antipsychotic use) were considered. In animal experiments, we observed significantly lower pH and higher lactate levels in the brains of model mice relative to controls, as well as a significant negative correlation between pH and lactate levels. Our findings suggest that lower pH associated with increased lactate levels is not a mere artifact, but rather implicated in the underlying pathophysiology of schizophrenia and bipolar disorder.
UR - http://www.scopus.com/inward/record.url?scp=85040451748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040451748&partnerID=8YFLogxK
U2 - 10.1038/npp.2017.167
DO - 10.1038/npp.2017.167
M3 - Article
C2 - 28776581
AN - SCOPUS:85040451748
SN - 0893-133X
VL - 43
SP - 459
EP - 468
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 3
ER -